These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34754394)

  • 21. The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.
    Kumar V; Shinagare AB; Rennke HG; Ghai S; Lorch JH; Ott PA; Rahma OE
    Oncologist; 2020 Jun; 25(6):505-514. PubMed ID: 32043699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of immuno-oncologic therapy in hepatocellular carcinoma in the context of liver transplantation. An interdisciplinary benefit/risk assessment].
    Vogel A; Sterneck M; Vondran F; Waidmann O; Klein I; Lindig U; Nadalin S; Settmacher U; Tacke F; Schlitt HJ; Wege H
    Z Gastroenterol; 2022 Feb; 60(2):184-191. PubMed ID: 34670296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review.
    Lominadze Z; Hill K; Shaik MR; Canakis JP; Bourmaf M; Adams-Mardi C; Abutaleb A; Mishra L; Shetty K
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with immunoglobulin improves outcome for pediatric liver transplant recipients.
    Bucuvalas JC; Anand R;
    Liver Transpl; 2009 Nov; 15(11):1564-9. PubMed ID: 19877216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.
    Mahmud N; John B; Taddei TH; Goldberg DS
    Clin Transplant; 2019 Jul; 33(7):e13634. PubMed ID: 31177570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].
    Pei F; Zheng J; Du J; Zhong HH; Yang JP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):408-14. PubMed ID: 18677390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B viral infection.
    Pei F; Shang K; Jiang B; Wang H; Mei F; Zhang Y; Du J; Zhong H; You J
    Hepatol Int; 2013 Jun; 7(2):468-76. PubMed ID: 26201779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients.
    Levitsky J; Goldberg D; Smith AR; Mansfield SA; Gillespie BW; Merion RM; Lok AS; Levy G; Kulik L; Abecassis M; Shaked A
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):584-593.e2. PubMed ID: 27567694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
    Liu YY; Li CP; Huai MS; Fu XM; Cui Z; Fan LL; Zhang S; Liu Y; Ma J; Li G; Shen ZY
    PLoS One; 2015; 10(3):e0120939. PubMed ID: 25816221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting survival after post-transplant hepatocellular carcinoma recurrence.
    Toso C; Cader S; Mentha-Dugerdil A; Meeberg G; Majno P; Morard I; Giostra E; Berney T; Morel P; Mentha G; Kneteman NM
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):342-7. PubMed ID: 22710887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Rich N; Tanriover B; Singal AG; Marrero JA
    Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection?
    Angelico R; Parente A; Manzia TM
    Transl Gastroenterol Hepatol; 2017; 2():74. PubMed ID: 29034347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database.
    Zhou J; Huang Z; Chen Z; Xu F; Tong R; Zheng S
    BMC Gastroenterol; 2021 Apr; 21(1):195. PubMed ID: 33931011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial experience with stereotactic body radiotherapy for intrahepatic hepatocellular carcinoma recurrence after liver transplantation.
    Au KP; Chiang CL; Chan ACY; Cheung TT; Lo CM; Chok KSH
    World J Clin Cases; 2020 Jul; 8(13):2758-2768. PubMed ID: 32742986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New scoring system identifies kidney outcome with radiation therapy in acute renal allograft rejection.
    Chen LM; Godinez J; Thisted RA; Woodle ES; Thistlewaite JR; Powers C; Haraf D
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):999-1003. PubMed ID: 10705023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients.
    Mao JX; Guo WY; Guo M; Liu C; Teng F; Ding GS
    Hepatol Int; 2020 May; 14(3):347-361. PubMed ID: 32140981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basiliximab: a review of its use as induction therapy in renal transplantation.
    Chapman TM; Keating GM
    Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
    Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
    Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.